1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 22 JUNE 2015

Cancer Drug News 22 JUNE 2015

  • June 2015
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - Gardasil 9 To Keep Merck On Top Of HPV Market
Industry Brief - Vaxil's ImMucin Gains FDA ODD For MM
Industry Trend Analysis - Myelofibrosis Market Changes Imminent
Industry Brief - Vosaroxin/Cytarabine Phase III Study Yields Positive Results In Older r/r AML Patients
Industry Brief - Phase II Tosedostat Combination Study Meets Primary Endpoint In Elderly AML Patients
Industry Brief - Vectibix Significantly Improves OS Versus Supportive Care In Phase III MCRC Study
Industry Trend Analysis - Anti-PD-1 Battle To Intensify In Europe
Industry Brief - OncoSec Enrols First Patient In Phase II ImmunoPulse IL-12 Trial In SCCHN
Industry Brief - VG Life Sciences Granted Combination Cancer Drug Patent
Industry Brief - Vaxon Granted Japanese Patent Covering Cancer Vaccine Candidates
Industry Brief - Western Oncolytics Raises Funds To Advance Cancer Oncolytic Immunotherapy
Industry Brief - Celyad Raises USD100.1mn With NASDAQ IPO
Industry Brief - CytomX Raises Funds To Advance Probody Therapeutics For Cancer
Industry Brief - Daiichi Sankyo Begins Phase III Edoxaban Study For Cancer-Associated VTE
Industry Brief - Cancer Conferences - September 2015

Table Of Contents

Cancer Drug News 22 JUNE 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.